Stephen S Galliker - Net Worth and Insider Trading
Stephen S Galliker Net Worth
The estimated net worth of Stephen S Galliker is at least $2 Million dollars as of 2024-09-21. Stephen S Galliker is the EVP and CFO of Dyax Corp and owns about 63,142 shares of Dyax Corp (DYAX) stock worth over $2 Million. Stephen S Galliker is also the Director of SELLAS Life Sciences Group Inc and owns about 0 shares of SELLAS Life Sciences Group Inc (SLS) stock worth over $0. Details can be seen in Stephen S Galliker's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Stephen S Galliker has not made any transactions after 2014-02-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Stephen S Galliker
Stephen S Galliker Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Stephen S Galliker owns 3 companies in total, including SELLAS Life Sciences Group Inc (SLS) , Kindred Biosciences Inc (KIN) , and Dyax Corp (DYAX) .
Click here to see the complete history of Stephen S Galliker’s form 4 insider trades.
Insider Ownership Summary of Stephen S Galliker
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SLS | SELLAS Life Sciences Group Inc | 2014-02-03 | director |
| KIN | Kindred Biosciences Inc | 2014-02-03 | Chief Financial Officer |
| DYAX | Dyax Corp | 2008-07-16 | EVP and CFO |
Stephen S Galliker Latest Holdings Summary
Stephen S Galliker currently owns a total of 2 stocks. Among these stocks, Stephen S Galliker owns 63,142 shares of Dyax Corp (DYAX) as of May 19, 2006, with a value of $2 Million and a weighting of 100%. Stephen S Galliker also owns 0 shares of SELLAS Life Sciences Group Inc (SLS) as of February 3, 2014, with a value of $0 and a weighting of 0%.
Latest Holdings of Stephen S Galliker
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DYAX | Dyax Corp | 2006-05-19 | 63,142 | 38.41 | 2,425,284 |
| SLS | SELLAS Life Sciences Group Inc | 2014-02-03 | 0 | 1.21 | 0 |
Holding Weightings of Stephen S Galliker
Stephen S Galliker Form 4 Trading Tracker
According to the SEC Form 4 filings, Stephen S Galliker has made a total of 0 transactions in Dyax Corp (DYAX) over the past 5 years. The most-recent trade in Dyax Corp is the acquisition of 10,000 shares on May 19, 2006, which cost Stephen S Galliker around $33,000.
According to the SEC Form 4 filings, Stephen S Galliker has made a total of 0 transactions in SELLAS Life Sciences Group Inc (SLS) over the past 5 years. The most-recent trade in SELLAS Life Sciences Group Inc is the sale of 10 shares on February 3, 2014, which brought Stephen S Galliker around $1 Million.
Insider Trading History of Stephen S Galliker
- 1
Stephen S Galliker Trading Performance
GuruFocus tracks the stock performance after each of Stephen S Galliker's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Stephen S Galliker is -13.55%. GuruFocus also compares Stephen S Galliker's trading performance to market benchmark return within the same time period. The performance of stocks bought by Stephen S Galliker within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Stephen S Galliker's insider trading performs compared to the benchmark.
Performance of Stephen S Galliker
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -10.84 | | | | | |
| Relative Return to S&P 500(%) | -8.72 | | | | | |
Stephen S Galliker Ownership Network
Stephen S Galliker Owned Company Details
What does SELLAS Life Sciences Group Inc do?
Who are the key executives at SELLAS Life Sciences Group Inc?
Stephen S Galliker is the director of SELLAS Life Sciences Group Inc. Other key executives at SELLAS Life Sciences Group Inc include EVP & Gen. Counsel & Corp. Sec. Barbara A Wood , VP & Finance & Corp Controller John Thomas Burns , and director & President and CEO Angelos M. Stergiou .
SELLAS Life Sciences Group Inc (SLS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of SELLAS Life Sciences Group Inc (SLS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of SELLAS Life Sciences Group Inc (SLS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
SELLAS Life Sciences Group Inc (SLS)'s detailed insider trading history can be found in Insider Trading Tracker table.
SELLAS Life Sciences Group Inc Insider Transactions
Stephen S Galliker Mailing Address
Above is the net worth, insider trading, and ownership report for Stephen S Galliker. You might contact Stephen S Galliker via mailing address: 300 Technology Square, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
